"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","characteristics_ch1.7","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","age at drawing:ch1","drawing year:ch1","er class:ch1","hemolysis score (hs):ch1","hs class:ch1","metastasis class:ch1","plasmaid:ch1","time from surgery:ch1","tissue:ch1"
"GSM1463189","US 13","GSM1463189","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 7570","drawing year: 1993","age at drawing: 42.76","time from surgery: 3.46","hemolysis score (hs): 0.031","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463189/suppl/GSM1463189_US11103886_253118111010_S01_miRNA_107_Sep09_2_3.txt.gz","1205","42.76","1993",NA,"0.031","no hemolysis",NA,"7570","3.46","plasma"
"GSM1463190","US 14","GSM1463190","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 7315","drawing year: 1993","age at drawing: 46.45","time from surgery: 3.12","hemolysis score (hs): 0.024","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463190/suppl/GSM1463190_US11103886_253118111010_S01_miRNA_107_Sep09_2_4.txt.gz","1205","46.45","1993",NA,"0.024","no hemolysis",NA,"7315","3.12","plasma"
"GSM1463196","US 23","GSM1463196","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 7055","drawing year: 1993","age at drawing: 57.81","time from surgery: 3.55","hemolysis score (hs): 0.052","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463196/suppl/GSM1463196_US11103886_253118111015_S01_miRNA_107_Sep09_1_3.txt.gz","1205","57.81","1993",NA,"0.052","no hemolysis",NA,"7055","3.55","plasma"
"GSM1463199","US 27","GSM1463199","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 6029","drawing year: 1992","age at drawing: 59.92","time from surgery: 3.55","hemolysis score (hs): 0.143","hs class: hemolyzed","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463199/suppl/GSM1463199_US11103886_253118111015_S01_miRNA_107_Sep09_2_3.txt.gz","1205","59.92","1992",NA,"0.143","hemolyzed",NA,"6029","3.55","plasma"
"GSM1463210","US 43","GSM1463210","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 5840","drawing year: 1991","age at drawing: 38.05","time from surgery: 3.45","hemolysis score (hs): 0.036","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463210/suppl/GSM1463210_US11103886_253118111030_S01_miRNA_107_Sep09_1_1.txt.gz","1205","38.05","1991",NA,"0.036","no hemolysis",NA,"5840","3.45","plasma"
"GSM1463212","US 48","GSM1463212","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 4178","drawing year: 1990","age at drawing: 51.08","time from surgery: 2.12","hemolysis score (hs): 0.04","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463212/suppl/GSM1463212_US11103886_253118111030_S01_miRNA_107_Sep09_2_2.txt.gz","1205","51.08","1990",NA,"0.04","no hemolysis",NA,"4178","2.12","plasma"
"GSM1463215","US 56","GSM1463215","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 4440","drawing year: 1990","age at drawing: 48.21","time from surgery: 1.87","hemolysis score (hs): 0.019","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463215/suppl/GSM1463215_US11103886_253118111031_S01_miRNA_107_Sep09_2_2.txt.gz","1205","48.21","1990",NA,"0.019","no hemolysis",NA,"4440","1.87","plasma"
"GSM1463221","US 194","GSM1463221","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 9151","drawing year: 1997","age at drawing: 62.07","time from surgery: 7.35","hemolysis score (hs): 0.016","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463221/suppl/GSM1463221_US11103886_253118111034_S01_miRNA_107_Sep09_2_2.txt.gz","1205","62.07","1997",NA,"0.016","no hemolysis",NA,"9151","7.35","plasma"
"GSM1463222","US 66","GSM1463222","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 9055","drawing year: 1997","age at drawing: 71.89","time from surgery: 7.55","hemolysis score (hs): 0.204","hs class: hemolyzed","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463222/suppl/GSM1463222_US11103886_253118111034_S01_miRNA_107_Sep09_2_3.txt.gz","1205","71.89","1997",NA,"0.204","hemolyzed",NA,"9055","7.55","plasma"
"GSM1463225","US 72","GSM1463225","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 8665","drawing year: 1995","age at drawing: 57.72","time from surgery: 6.21","hemolysis score (hs): 0.056","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463225/suppl/GSM1463225_US11103886_253118111036_S01_miRNA_107_Sep09_2_4.txt.gz","1205","57.72","1995",NA,"0.056","no hemolysis",NA,"8665","6.21","plasma"
"GSM1463227","US 78","GSM1463227","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 4310","drawing year: 1990","age at drawing: 52.09","time from surgery: 1.5","hemolysis score (hs): 0.024","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463227/suppl/GSM1463227_US11103886_253118111038_S01_miRNA_107_Sep09_1_2.txt.gz","1205","52.09","1990",NA,"0.024","no hemolysis",NA,"4310","1.5","plasma"
"GSM1463228","US 82","GSM1463228","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 4726","drawing year: 1990","age at drawing: 62.45","time from surgery: 1.1","hemolysis score (hs): 0.035","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463228/suppl/GSM1463228_US11103886_253118111038_S01_miRNA_107_Sep09_1_4.txt.gz","1205","62.45","1990",NA,"0.035","no hemolysis",NA,"4726","1.1","plasma"
"GSM1463234","US 90","GSM1463234","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 1595","drawing year: 1988","age at drawing: 37.35","time from surgery: 1.97","hemolysis score (hs): 0.029","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463234/suppl/GSM1463234_US11103886_253118111039_S01_miRNA_107_Sep09_1_4.txt.gz","1205","37.35","1988",NA,"0.029","no hemolysis",NA,"1595","1.97","plasma"
"GSM1463240","US 109","GSM1463240","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 8673","drawing year: 1995","age at drawing: 45.1","time from surgery: 4.49","hemolysis score (hs): 0.03","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463240/suppl/GSM1463240_US11103886_253118111058_S01_miRNA_107_Sep09_1_1.txt.gz","1205","45.1","1995",NA,"0.03","no hemolysis",NA,"8673","4.49","plasma"
"GSM1463241","US 110","GSM1463241","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 8657","drawing year: 1995","age at drawing: 50.06","time from surgery: 5.38","hemolysis score (hs): 0.051","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463241/suppl/GSM1463241_US11103886_253118111058_S01_miRNA_107_Sep09_1_2.txt.gz","1205","50.06","1995",NA,"0.051","no hemolysis",NA,"8657","5.38","plasma"
"GSM1463244","US 114","GSM1463244","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 8879","drawing year: 1996","age at drawing: 70.21","time from surgery: 13.68","hemolysis score (hs): 0.049","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463244/suppl/GSM1463244_US11103886_253118111058_S01_miRNA_107_Sep09_2_4.txt.gz","1205","70.21","1996",NA,"0.049","no hemolysis",NA,"8879","13.68","plasma"
"GSM1463245","US 117","GSM1463245","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 9070","drawing year: 1997","age at drawing: 67.84","time from surgery: 8.77","hemolysis score (hs): 0.03","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463245/suppl/GSM1463245_US11103886_253118111059_S01_miRNA_107_Sep09_1_3.txt.gz","1205","67.84","1997",NA,"0.03","no hemolysis",NA,"9070","8.77","plasma"
"GSM1463246","US 118","GSM1463246","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 9036","drawing year: 1997","age at drawing: 54.33","time from surgery: 7.95","hemolysis score (hs): 0.036","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463246/suppl/GSM1463246_US11103886_253118111059_S01_miRNA_107_Sep09_1_4.txt.gz","1205","54.33","1997",NA,"0.036","no hemolysis",NA,"9036","7.95","plasma"
"GSM1463256","US 175","GSM1463256","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 9366","drawing year: 1999","age at drawing: 53.01","time from surgery: 6.76","hemolysis score (hs): 0.047","hs class: no hemolysis","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463256/suppl/GSM1463256_US11103886_253118111102_S01_miRNA_107_Sep09_1_1.txt.gz","1205","53.01","1999",NA,"0.047","no hemolysis",NA,"9366","6.76","plasma"
"GSM1463257","US 177","GSM1463257","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 2481","drawing year: 1988","age at drawing: 59.02","time from surgery: 2.32","hemolysis score (hs): 0.42","hs class: hemolyzed","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463257/suppl/GSM1463257_US11103886_253118111102_S01_miRNA_107_Sep09_1_3.txt.gz","1205","59.02","1988",NA,"0.42","hemolyzed",NA,"2481","2.32","plasma"
"GSM1463259","US 187","GSM1463259","Public on Aug 01 2014","Jul 31 2014","Apr 28 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 8139","drawing year: 1994","age at drawing: 50.99","time from surgery: 5.5","hemolysis score (hs): 0.63","hs class: hemolyzed","","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1463nnn/GSM1463259/suppl/GSM1463259_US11103886_253118111103_S01_miRNA_107_Sep09_2_3.txt.gz","1205","50.99","1994",NA,"0.63","hemolyzed",NA,"8139","5.5","plasma"
"GSM1669444","US 17","GSM1669444","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 6454","er class: pos","drawing year: 1992","age at drawing: 69.13","time from surgery: 4.58","hemolysis score (hs): 0.093","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669444/suppl/GSM1669444_US11103886_253118111014_S01_miRNA_107_Sep09_2_1.txt.gz","1205","69.13","1992","pos","0.093",NA,"metastasis","6454","4.58","plasma"
"GSM1669445","US 18","GSM1669445","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 6021","er class: pos","drawing year: 1992","age at drawing: 54.19","time from surgery: 4.25","hemolysis score (hs): 0.046","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669445/suppl/GSM1669445_US11103886_253118111014_S01_miRNA_107_Sep09_2_2.txt.gz","1205","54.19","1992","pos","0.046",NA,"no metastasis","6021","4.25","plasma"
"GSM1669447","US 24","GSM1669447","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 6212","er class: pos","drawing year: 1992","age at drawing: 54","time from surgery: 4.12","hemolysis score (hs): 0.053","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669447/suppl/GSM1669447_US11103886_253118111015_S01_miRNA_107_Sep09_1_4.txt.gz","1205","54","1992","pos","0.053",NA,"no metastasis","6212","4.12","plasma"
"GSM1669449","US 28","GSM1669449","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 5932","er class: neg","drawing year: 1992","age at drawing: 58.54","time from surgery: 4.43","hemolysis score (hs): 0.023","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669449/suppl/GSM1669449_US11103886_253118111015_S01_miRNA_107_Sep09_2_4.txt.gz","1205","58.54","1992","neg","0.023",NA,"no metastasis","5932","4.43","plasma"
"GSM1669451","US 45","GSM1669451","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 3557","er class: pos","drawing year: 1989","age at drawing: 55.02","time from surgery: 5.7","hemolysis score (hs): 0.087","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669451/suppl/GSM1669451_US11103886_253118111030_S01_miRNA_107_Sep09_1_3.txt.gz","1205","55.02","1989","pos","0.087",NA,"no metastasis","3557","5.7","plasma"
"GSM1669452","US 46","GSM1669452","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 3808","er class: pos","drawing year: 1989","age at drawing: 54.62","time from surgery: 5.05","hemolysis score (hs): 0.111","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669452/suppl/GSM1669452_US11103886_253118111030_S01_miRNA_107_Sep09_1_4.txt.gz","1205","54.62","1989","pos","0.111",NA,"metastasis","3808","5.05","plasma"
"GSM1669453","US 47","GSM1669453","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 4147","er class: neg","drawing year: 1990","age at drawing: 43.18","time from surgery: 2.8","hemolysis score (hs): 0.037","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669453/suppl/GSM1669453_US11103886_253118111030_S01_miRNA_107_Sep09_2_1.txt.gz","1205","43.18","1990","neg","0.037",NA,"no metastasis","4147","2.8","plasma"
"GSM1669455","US 55","GSM1669455","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 3475","er class: neg","drawing year: 1989","age at drawing: 37.8","time from surgery: 0.81","hemolysis score (hs): 0.034","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669455/suppl/GSM1669455_US11103886_253118111031_S01_miRNA_107_Sep09_2_1.txt.gz","1205","37.8","1989","neg","0.034",NA,"no metastasis","3475","0.81","plasma"
"GSM1669459","US 71","GSM1669459","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 8666","er class: pos","drawing year: 1995","age at drawing: 57.24","time from surgery: 6.06","hemolysis score (hs): 0.077","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669459/suppl/GSM1669459_US11103886_253118111036_S01_miRNA_107_Sep09_2_3.txt.gz","1205","57.24","1995","pos","0.077",NA,"no metastasis","8666","6.06","plasma"
"GSM1669461","US 77","GSM1669461","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 3532","er class: neg","drawing year: 1989","age at drawing: 60.82","time from surgery: 3.16","hemolysis score (hs): 0.07","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669461/suppl/GSM1669461_US11103886_253118111038_S01_miRNA_107_Sep09_1_1.txt.gz","1205","60.82","1989","neg","0.07",NA,"no metastasis","3532","3.16","plasma"
"GSM1669463","US 81","GSM1669463","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 4111","er class: neg","drawing year: 1990","age at drawing: 60.41","time from surgery: 0.7","hemolysis score (hs): 0.022","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669463/suppl/GSM1669463_US11103886_253118111038_S01_miRNA_107_Sep09_1_3.txt.gz","1205","60.41","1990","neg","0.022",NA,"no metastasis","4111","0.7","plasma"
"GSM1669465","US 89","GSM1669465","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 631","er class: pos","drawing year: 1987","age at drawing: 47.41","time from surgery: 1.71","hemolysis score (hs): 0.034","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669465/suppl/GSM1669465_US11103886_253118111039_S01_miRNA_107_Sep09_1_3.txt.gz","1205","47.41","1987","pos","0.034",NA,"no metastasis","631","1.71","plasma"
"GSM1669467","US 95","GSM1669467","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 5464","er class: pos","drawing year: 1991","age at drawing: 64.89","time from surgery: 4.18","hemolysis score (hs): 0.009","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669467/suppl/GSM1669467_US11103886_253118111040_S01_miRNA_107_Sep09_1_1.txt.gz","1205","64.89","1991","pos","0.009",NA,"no metastasis","5464","4.18","plasma"
"GSM1669468","US 96","GSM1669468","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 5890","er class: pos","drawing year: 1991","age at drawing: 53.75","time from surgery: 4.16","hemolysis score (hs): 0.034","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669468/suppl/GSM1669468_US11103886_253118111040_S01_miRNA_107_Sep09_1_2.txt.gz","1205","53.75","1991","pos","0.034",NA,"metastasis","5890","4.16","plasma"
"GSM1669471","US 113","GSM1669471","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 8662","er class: pos","drawing year: 1995","age at drawing: 66.61","time from surgery: 14.67","hemolysis score (hs): 0.065","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669471/suppl/GSM1669471_US11103886_253118111058_S01_miRNA_107_Sep09_2_3.txt.gz","1205","66.61","1995","pos","0.065",NA,"metastasis","8662","14.67","plasma"
"GSM1669475","US 121","GSM1669475","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 3923","er class: pos","drawing year: 1990","age at drawing: 55.3","time from surgery: 4.87","hemolysis score (hs): 0.058","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669475/suppl/GSM1669475_US11103886_253118111059_S01_miRNA_107_Sep09_2_3.txt.gz","1205","55.3","1990","pos","0.058",NA,"metastasis","3923","4.87","plasma"
"GSM1669476","US 122","GSM1669476","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 3589","er class: pos","drawing year: 1989","age at drawing: 66.44","time from surgery: 4.25","hemolysis score (hs): 0.068","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669476/suppl/GSM1669476_US11103886_253118111059_S01_miRNA_107_Sep09_2_4.txt.gz","1205","66.44","1989","pos","0.068",NA,"no metastasis","3589","4.25","plasma"
"GSM1669477","US 123","GSM1669477","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 6797","er class: pos","drawing year: 1992","age at drawing: 54.38","time from surgery: 6.58","hemolysis score (hs): 0.042","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669477/suppl/GSM1669477_US11103886_253118111061_S01_miRNA_107_Sep09_1_1.txt.gz","1205","54.38","1992","pos","0.042",NA,"metastasis","6797","6.58","plasma"
"GSM1669478","US 124","GSM1669478","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 6205","er class: pos","drawing year: 1992","age at drawing: 59.38","time from surgery: 6.82","hemolysis score (hs): 0.049","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669478/suppl/GSM1669478_US11103886_253118111061_S01_miRNA_107_Sep09_1_2.txt.gz","1205","59.38","1992","pos","0.049",NA,"no metastasis","6205","6.82","plasma"
"GSM1669479","US 127","GSM1669479","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 2417","er class: pos","drawing year: 1988","age at drawing: 59.29","time from surgery: 6.09","hemolysis score (hs): 0.076","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669479/suppl/GSM1669479_US11103886_253118111061_S01_miRNA_107_Sep09_2_1.txt.gz","1205","59.29","1988","pos","0.076",NA,"metastasis","2417","6.09","plasma"
"GSM1669480","US 128","GSM1669480","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 1029","er class: pos","drawing year: 1988","age at drawing: 59.61","time from surgery: 6.44","hemolysis score (hs): 0.091","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669480/suppl/GSM1669480_US11103886_253118111061_S01_miRNA_107_Sep09_2_2.txt.gz","1205","59.61","1988","pos","0.091",NA,"no metastasis","1029","6.44","plasma"
"GSM1669481","US 131","GSM1669481","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 5784","er class: neg","drawing year: 1991","age at drawing: 60.18","time from surgery: 4.34","hemolysis score (hs): 0.027","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669481/suppl/GSM1669481_US11103886_253118111073_S01_miRNA_107_Sep09_1_1.txt.gz","1205","60.18","1991","neg","0.027",NA,"metastasis","5784","4.34","plasma"
"GSM1669482","US 132","GSM1669482","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 5122","er class: neg","drawing year: 1991","age at drawing: 55.09","time from surgery: 4.25","hemolysis score (hs): 0.076","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669482/suppl/GSM1669482_US11103886_253118111073_S01_miRNA_107_Sep09_1_2.txt.gz","1205","55.09","1991","neg","0.076",NA,"no metastasis","5122","4.25","plasma"
"GSM1669483","US 139","GSM1669483","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 7253","er class: pos","drawing year: 1993","age at drawing: 65.75","time from surgery: 5.54","hemolysis score (hs): 0.022","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669483/suppl/GSM1669483_US11103886_253118111074_S01_miRNA_107_Sep09_1_1.txt.gz","1205","65.75","1993","pos","0.022",NA,"metastasis","7253","5.54","plasma"
"GSM1669484","US 140","GSM1669484","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 6241","er class: pos","drawing year: 1992","age at drawing: 58.2","time from surgery: 5.7","hemolysis score (hs): 0.037","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669484/suppl/GSM1669484_US11103886_253118111074_S01_miRNA_107_Sep09_1_2.txt.gz","1205","58.2","1992","pos","0.037",NA,"no metastasis","6241","5.7","plasma"
"GSM1669485","US 151","GSM1669485","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 6285","er class: pos","drawing year: 1992","age at drawing: 66.18","time from surgery: 3.78","hemolysis score (hs): 0.054","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669485/suppl/GSM1669485_US11103886_253118111075_S01_miRNA_107_Sep09_2_3.txt.gz","1205","66.18","1992","pos","0.054",NA,"metastasis","6285","3.78","plasma"
"GSM1669486","US 152","GSM1669486","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 5791","er class: pos","drawing year: 1991","age at drawing: 55.06","time from surgery: 3.47","hemolysis score (hs): 0.12","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669486/suppl/GSM1669486_US11103886_253118111075_S01_miRNA_107_Sep09_2_4.txt.gz","1205","55.06","1991","pos","0.12",NA,"no metastasis","5791","3.47","plasma"
"GSM1669487","US 157","GSM1669487","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 6554","er class: pos","drawing year: 1992","age at drawing: 61.65","time from surgery: 5.9","hemolysis score (hs): 0.097","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669487/suppl/GSM1669487_US11103886_253118111098_S01_miRNA_107_Sep09_2_1.txt.gz","1205","61.65","1992","pos","0.097",NA,"metastasis","6554","5.9","plasma"
"GSM1669488","US 158","GSM1669488","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 5973","er class: pos","drawing year: 1992","age at drawing: 59.71","time from surgery: 6.25","hemolysis score (hs): 0.036","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669488/suppl/GSM1669488_US11103886_253118111098_S01_miRNA_107_Sep09_2_2.txt.gz","1205","59.71","1992","pos","0.036",NA,"no metastasis","5973","6.25","plasma"
"GSM1669489","US 161","GSM1669489","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 7080","er class: pos","drawing year: 1993","age at drawing: 55.68","time from surgery: 0.78","hemolysis score (hs): 0.037","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669489/suppl/GSM1669489_US11103886_253118111099_S01_miRNA_107_Sep09_1_1.txt.gz","1205","55.68","1993","pos","0.037",NA,"metastasis","7080","0.78","plasma"
"GSM1669490","US 162","GSM1669490","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 6602","er class: pos","drawing year: 1992","age at drawing: 69.92","time from surgery: 1.02","hemolysis score (hs): 0.054","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669490/suppl/GSM1669490_US11103886_253118111099_S01_miRNA_107_Sep09_1_2.txt.gz","1205","69.92","1992","pos","0.054",NA,"no metastasis","6602","1.02","plasma"
"GSM1669491","US 169","GSM1669491","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 7515","er class: neg","drawing year: 1993","age at drawing: 55.02","time from surgery: 3.08","hemolysis score (hs): 0.041","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669491/suppl/GSM1669491_US11103886_253118111100_S01_miRNA_107_Sep09_1_1.txt.gz","1205","55.02","1993","neg","0.041",NA,"metastasis","7515","3.08","plasma"
"GSM1669492","US 170","GSM1669492","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 7732","er class: neg","drawing year: 1993","age at drawing: 60.85","time from surgery: 2.5","hemolysis score (hs): 0.107","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669492/suppl/GSM1669492_US11103886_253118111100_S01_miRNA_107_Sep09_1_2.txt.gz","1205","60.85","1993","neg","0.107",NA,"no metastasis","7732","2.5","plasma"
"GSM1669493","US 44b","GSM1669493","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 5186","er class: pos","drawing year: 1991","age at drawing: 43.79","time from surgery: 4.64","hemolysis score (hs): 0.045","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669493/suppl/GSM1669493_US11103886_253118111100_S01_miRNA_107_Sep09_1_4.txt.gz","1205","43.79","1991","pos","0.045",NA,"metastasis","5186","4.64","plasma"
"GSM1669495","US 176","GSM1669495","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 9299","er class: neg","drawing year: 1998","age at drawing: 57.33","time from surgery: 7.38","hemolysis score (hs): 0.072","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669495/suppl/GSM1669495_US11103886_253118111102_S01_miRNA_107_Sep09_1_2.txt.gz","1205","57.33","1998","neg","0.072",NA,"no metastasis","9299","7.38","plasma"
"GSM1669497","US 178","GSM1669497","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 1219","er class: pos","drawing year: 1988","age at drawing: 53.31","time from surgery: 2.34","hemolysis score (hs): 0.031","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669497/suppl/GSM1669497_US11103886_253118111102_S01_miRNA_107_Sep09_1_4.txt.gz","1205","53.31","1988","pos","0.031",NA,"no metastasis","1219","2.34","plasma"
"GSM1669498","US 179","GSM1669498","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 3836","er class: pos","drawing year: 1989","age at drawing: 64.85","time from surgery: 0.56","hemolysis score (hs): 0.075","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669498/suppl/GSM1669498_US11103886_253118111102_S01_miRNA_107_Sep09_2_1.txt.gz","1205","64.85","1989","pos","0.075",NA,"metastasis","3836","0.56","plasma"
"GSM1669499","US 180","GSM1669499","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 3783","er class: pos","drawing year: 1989","age at drawing: 67.47","time from surgery: 0.76","hemolysis score (hs): 0.046","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669499/suppl/GSM1669499_US11103886_253118111102_S01_miRNA_107_Sep09_2_2.txt.gz","1205","67.47","1989","pos","0.046",NA,"no metastasis","3783","0.76","plasma"
"GSM1669500","US 181","GSM1669500","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 5920","er class: pos","drawing year: 1992","age at drawing: 62.74","time from surgery: 0.54","hemolysis score (hs): 0.075","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669500/suppl/GSM1669500_US11103886_253118111102_S01_miRNA_107_Sep09_2_3.txt.gz","1205","62.74","1992","pos","0.075",NA,"metastasis","5920","0.54","plasma"
"GSM1669501","US 182","GSM1669501","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 6090","er class: pos","drawing year: 1992","age at drawing: 52.9","time from surgery: 0.6","hemolysis score (hs): 0.112","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669501/suppl/GSM1669501_US11103886_253118111102_S01_miRNA_107_Sep09_2_4.txt.gz","1205","52.9","1992","pos","0.112",NA,"no metastasis","6090","0.6","plasma"
"GSM1669502","US 183","GSM1669502","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 3973","er class: pos","drawing year: 1990","age at drawing: 41.91","time from surgery: 1.43","hemolysis score (hs): 0.045","metastasis class: metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669502/suppl/GSM1669502_US11103886_253118111103_S01_miRNA_107_Sep09_1_3.txt.gz","1205","41.91","1990","pos","0.045",NA,"metastasis","3973","1.43","plasma"
"GSM1669503","US 184","GSM1669503","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 4125","er class: pos","drawing year: 1990","age at drawing: 46.63","time from surgery: 0.9","hemolysis score (hs): 0.077","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669503/suppl/GSM1669503_US11103886_253118111103_S01_miRNA_107_Sep09_1_4.txt.gz","1205","46.63","1990","pos","0.077",NA,"no metastasis","4125","0.9","plasma"
"GSM1669505","US 188","GSM1669505","Public on Aug 31 2015","Apr 28 2015","Aug 31 2015","RNA","1","plasma","Homo sapiens","tissue: plasma","plasmaid: 8075","er class: pos","drawing year: 1994","age at drawing: 43.92","time from surgery: 5.35","hemolysis score (hs): 0.105","metastasis class: no metastasis","Plasma samples used in this study belong to the human plasma collection of the Fenretinide Breast Cancer Prevention Trial and RNA was extracted from 350 μl of sample.","total RNA","Total RNA was extracted from plasma using the commercial column-based system Qiagen miRNeasy® Mini Kit (Qiagen, Valencia, CA, USA), slightly modified by Exiqon (Vedbaek, Denmark. The eluate was digested using 1 u/µl heparinase I (Sigma-Aldrich, St. Luis, MO, USA), in the presence of an RNase inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was stored at −80 °C.","Cy3","2.5 μl of total RNA was dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% DMSO at 100°C for  5 min, labeled with pCp-Cy3 using T4 ligase by incubation at 16°C for 1 hour","9606","Hybridization for 20 h at 55 °C on SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) designed on miRBase 16.0 from Agilent Technologies. The arrays were washed in Agilent GE Wash Buffers, following the manufacturer’s instructions","All slides were immediately scanned at 2 mm resolution using an Agilent DNA microarray scanner","miRNA profile of archival plasma sample","The resulting images were analyzed using Agilent’s Feature Extraction software v10.7. In the employed platform, each miRNA is targeted by one to 4 different probes and each probe is spotted 10 to 40 times on the array. Then, the total gene signal for each miRNA was obtained by summing the probe signals derived using the Agilent Feature Extraction software. Using this software, each probe is defined detected if its value is greater than 3 times its standard error, and each miRNA is defined as detected if at least one of the probes is detected. Summarized data were log2 transformed","GPL16770","Elena,,Landoni","elena.landoni@istitutotumori.mi.it","Fondazione IRCCS Istituto Nazionale dei Tumori","Via Vanzetti 5","Milano","20133","Italy","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1669nnn/GSM1669505/suppl/GSM1669505_US11103886_253118111103_S01_miRNA_107_Sep09_2_4.txt.gz","1205","43.92","1994","pos","0.105",NA,"no metastasis","8075","5.35","plasma"
